✦ LIBER ✦

NN2211: a long-acting glucagon-like peptide-1 derivative with anti-diabetic effects in glucose-intolerant pigs

✍ Scribed by Ulla Ribel; Marianne O Larsen; Bidda Rolin; Richard D Carr; Michael Wilken; Jeppe Sturis; Lisbet Westergaard; Carolyn F Deacon; Lotte Bjerre Knudsen

Book ID: 114015007
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 208 KB
Volume: 451
Category: Article
ISSN: 0014-2999
DOI: 10.1016/s0014-2999(02)02189-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of liraglutide (NN2211), a long-

Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes

✍ M. N. Feinglos; M. F. Saad; F. X. Pi-Sunyer; B. An; O. Santiago; on behalf of th 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Pharmacodynamics, Pharmacokinetics, Safe

Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Albiglutide, a Long-Acting Glucagon-Like Peptide-1 Mimetic, in Patients with Type 2 Diabetes

✍ Matthews, Jessica E.; Stewart, Murray W.; De Boever, Erika H.; Dobbins, Robert L 📂 Article 📅 2008 🏛 Endocrine Society 🌐 English ⚖ 156 KB

Effects of the long-acting human glucago

Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus

✍ Pijun Yan; Ling Li; Mengliu Yang; Dongfang Liu; Hua Liu; Guenther Boden; Gangyi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Anti-inflammatory effects of exendin-4,

Anti-inflammatory effects of exendin-4, a glucagon-like peptide-1 analog, on human peripheral lymphocytes in patients with type 2 diabetes

✍ He, Lan; Wong, Chun Kwok; Cheung, Kitty KT; Yau, Ho Chung; Fu, Anthony; Zhao, Ha 📂 Article 📅 2013 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 417 KB

A 5-week study of the pharmacokinetics a

A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes

✍ P. Barrington; J. Y. Chien; H. D. H. Showalter; K. Schneck; S. Cui; F. Tibaldi; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB

The effects of LY2189265, a long-acting

The effects of LY2189265, a long-acting glucagon-like peptide-1 analogue, in a randomized, placebo-controlled, double-blind study of overweight/obese patients with type 2 diabetes: the EGO study

✍ G. E. Umpierrez; T. Blevins; J. Rosenstock; C. Cheng; J. H. Anderson; E. J. Bast 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 652 KB